Researchers: Comorbidities raise MERS mortality risks

07/26/2013 | Medscape (free registration)

Middle East respiratory syndrome is clinically different than severe acute respiratory syndrome and can lead to significant mortality rates in hospital patients who have comorbidities, according to a study in the Lancet Infectious Diseases. Researchers from Saudi Arabia said MERS can progress to respiratory failure five days earlier than SARS, although SARS appears to be more infectious in health care settings.

View Full Article in:

Medscape (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA